Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,17206,307,3.81 [1.92-7.54],0.0001234082375788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19301,331,1.39 [1.24-1.55],1.131165166766276e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,17214,308,2.82 [1.88-4.24],5.120033171797598e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,19402,328,1.52 [1.29-1.79],3.940651219674426e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,16814,295,1.42 [1.04-1.95],0.0285238079674712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,17141,308,1.11 [1.01-1.23],0.0347567925286644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,16677,295,0.67 [0.51-0.89],0.0051873736737292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,19854,339,1.76 [1.32-2.36],0.0001333262638592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,19916,343,1.20 [1.02-1.41],0.0259881115904162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,16677,295,0.83 [0.73-0.94],0.0039144107139033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",19402,328,1.29 [1.06-1.58],0.0125388007349687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,19556,336,2.17 [1.54-3.06],8.605383283370498e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,19764,335,1.26 [1.08-1.46],0.0026201489084003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,16602,297,1.32 [1.09-1.61],0.0046052384525607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,20006,342,1.45 [1.13-1.87],0.0033614639341936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,19667,335,2.00 [1.62-2.46],5.94705794610907e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,16677,295,2.35 [1.79-3.07],5.0283103508214e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,19402,328,1.96 [1.42-2.71],4.567372679596623e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,19592,336,0.49 [0.37-0.64],2.4102126373189295e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,20006,342,0.69 [0.53-0.89],0.0038931566140908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,19917,341,1.75 [1.29-2.39],0.0003539367507623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17141,308,2.26 [1.63-3.12],8.818045561701964e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,16677,295,1.76 [1.29-2.40],0.0003735810563926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,20015,341,0.49 [0.33-0.74],0.0005698138986228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,19668,335,1.45 [1.14-1.85],0.0026342342741036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,16677,295,1.43 [1.06-1.93],0.0204243563293496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,17201,308,3.31 [2.55-4.29],2.615829502385287e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,16725,292,1.66 [1.04-2.65],0.0351438407635839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,16814,295,2.30 [1.80-2.93],1.6483492533067373e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,17141,308,1.39 [1.14-1.70],0.0013253306707852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,19668,335,1.37 [1.24-1.52],2.163835149692111e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,17206,307,1.49 [1.27-1.75],1.4431905698563929e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,19939,343,3.84 [2.65-5.55],9.090145844150761e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,19188,325,1.16 [1.04-1.29],0.0059177438309891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,19840,341,1.66 [1.30-2.12],5.593062897389167e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,19764,335,1.18 [1.04-1.34],0.009862595725459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,19301,331,1.28 [1.05-1.55],0.0125265780064371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",19641,335,1.21 [1.11-1.33],3.197835839933669e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,16735,300,1.33 [1.13-1.56],0.0006100780001498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,20015,341,2.32 [1.46-3.66],0.0003311861144001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,19776,339,1.24 [1.05-1.48],0.0138590721354897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",19716,332,1.28 [1.13-1.45],7.244473770534162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",17167,307,1.53 [1.23-1.90],0.0001160369987713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",19668,335,1.25 [1.16-1.35],5.360718622324482e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,19668,335,1.69 [1.10-2.58],0.0165883036676894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,19045,326,0.71 [0.58-0.88],0.0017606032484382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,18449,320,0.67 [0.54-0.83],0.0002557437685481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,19733,336,1.47 [1.10-1.96],0.0098563621811808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,19939,343,3.02 [2.41-3.77],5.0698333776352e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,19459,324,2.56 [1.82-3.61],7.805310115670452e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,19770,340,1.36 [1.07-1.74],0.0117272823734445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,19802,337,1.68 [1.26-2.25],0.0004525499281058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,19811,340,1.99 [1.60-2.46],2.9208020371272144e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,19939,343,1.36 [1.05-1.75],0.0182981360611958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,19839,338,1.66 [1.17-2.38],0.004997797050426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,19332,331,1.38 [1.24-1.54],4.334232476050843e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,16477,288,1.21 [1.04-1.41],0.0140487309471102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,19867,338,2.83 [2.04-3.93],5.497366473145606e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,19764,335,0.60 [0.49-0.73],6.682394829069546e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,17214,308,1.27 [1.02-1.59],0.0361241182525169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,19668,335,2.75 [2.27-3.33],6.326671754291632e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,16602,297,1.22 [1.04-1.43],0.0160080613882298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,19668,335,1.20 [1.01-1.43],0.0361407950883022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,19413,332,1.24 [1.03-1.50],0.0253289033559954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,17042,307,1.49 [1.20-1.85],0.0003719655534751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,19592,336,2.43 [1.81-3.25],2.9070502919065244e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,17214,308,2.01 [1.34-3.00],0.0006802730644455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,17199,308,1.80 [1.30-2.49],0.0003909279549792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,16602,297,0.80 [0.69-0.93],0.003502543329439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,19829,337,1.24 [1.07-1.43],0.0041601558952519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,17141,308,1.56 [1.16-2.10],0.0032590253756174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,17206,307,1.71 [1.34-2.17],1.1912836723094514e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",16725,292,1.69 [1.23-2.32],0.0011846515110801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",19840,341,2.15 [1.53-3.01],9.447659990024412e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,19556,336,0.72 [0.57-0.91],0.0060183969349283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,19301,331,1.27 [1.10-1.47],0.0010699519987944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,19776,339,2.34 [1.61-3.39],6.979856836187165e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,19592,336,0.29 [0.22-0.39],1.0521161502266717e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",17199,308,1.68 [1.24-2.27],0.0007926790399857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,16902,301,0.50 [0.34-0.73],0.0003947547029337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,16814,295,1.98 [1.30-3.00],0.0013191408467384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,19370,327,1.30 [1.01-1.68],0.0381734730435198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,16814,295,2.86 [1.88-4.36],1.0370502255341188e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,16677,295,1.36 [1.05-1.74],0.0179041302826626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,19738,336,1.57 [1.34-1.83],1.3522939078042569e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,17167,307,1.46 [1.10-1.94],0.0083981403319147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,19972,341,3.99 [2.58-6.17],5.018376937347292e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,19950,342,1.65 [1.43-1.90],9.672583193517927e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,17206,307,0.57 [0.33-0.97],0.039870743930793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,19840,341,1.88 [1.34-2.65],0.0002925851878068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,19752,333,1.59 [1.24-2.05],0.0002896002668558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,19910,341,2.04 [1.35-3.08],0.0006734613705342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,19867,338,1.84 [1.49-2.26],1.0971985712595052e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,16814,295,1.45 [1.05-2.00],0.0237171797153839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,17167,307,1.49 [1.11-2.01],0.0087311103669878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,17206,307,1.98 [1.25-3.13],0.0035943161221928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,17206,307,2.22 [1.35-3.66],0.0017086985239191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,19837,338,1.68 [1.04-2.72],0.0324586305993683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,19305,331,1.31 [1.04-1.66],0.023821372496301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,16358,289,1.42 [1.15-1.76],0.0010417893812936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,17206,307,2.64 [1.35-5.17],0.0047249239147223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,16796,302,4.36 [3.24-5.87],2.7110245276473724e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,17206,307,1.46 [1.00-2.13],0.0488728900164132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,17214,308,1.35 [1.11-1.65],0.0032702991752661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,19668,335,1.77 [1.36-2.32],2.666672671315016e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,19939,343,0.46 [0.35-0.60],1.4771341135959252e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,20015,341,2.62 [1.78-3.87],1.2492005926668977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",19402,328,1.14 [1.03-1.27],0.0109579455173753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,19716,339,0.69 [0.59-0.81],2.8709975283362844e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,19939,343,1.66 [1.39-1.98],3.3758658652852955e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,16735,300,1.39 [1.08-1.78],0.0107844466047397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,19332,331,1.34 [1.00-1.80],0.049188779427182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,19565,336,1.31 [1.15-1.49],3.213812040296939e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,17155,308,1.33 [1.03-1.73],0.0313554057437456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,19628,337,1.24 [1.06-1.45],0.0074750692612487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,17140,308,1.37 [1.07-1.76],0.0124683398720422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,17155,308,1.14 [1.03-1.25],0.0083109608263416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,19737,335,1.16 [1.02-1.33],0.0290148626727053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,19939,343,0.65 [0.48-0.88],0.0058040892354535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,16725,292,1.27 [1.03-1.57],0.0242219223492103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,19764,335,2.18 [1.71-2.79],5.079001426682359e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,20006,342,1.56 [1.21-2.03],0.0006934248397334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,20015,341,1.45 [1.18-1.78],0.0004193518655355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,20015,341,1.41 [1.16-1.71],0.0005247878198164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,19699,338,1.22 [1.10-1.35],0.0002288198311085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,19950,342,1.10 [1.02-1.18],0.015965519089267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,20006,342,1.44 [1.32-1.57],1.4031093717485746e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,19840,341,2.33 [1.93-2.81],8.78938734269767e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,19542,333,1.75 [1.48-2.08],7.231458744759593e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,20006,342,1.32 [1.08-1.61],0.0059506533027872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,19764,335,1.19 [1.01-1.40],0.0337756390098148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,19689,330,1.42 [1.22-1.66],6.4874521661004095e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,19752,333,1.41 [1.22-1.64],5.279362264856313e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,19640,333,1.17 [1.02-1.35],0.0232305691173472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,19979,339,1.79 [1.38-2.31],1.0644361347706907e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,19939,343,1.38 [1.08-1.76],0.0093225592396299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,17141,308,1.43 [1.09-1.87],0.0096015483521837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,19776,339,1.39 [1.03-1.88],0.0314862615617297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,19405,329,2.11 [1.68-2.64],7.015741651058716e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,19867,338,1.90 [1.54-2.34],1.907499232181312e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,19306,327,1.39 [1.08-1.80],0.0110749496807113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,17201,308,0.75 [0.57-0.99],0.0397216463580876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,19829,337,1.98 [1.61-2.42],5.863090552784585e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,19592,336,1.94 [1.50-2.50],3.165027088188447e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,19740,338,2.13 [1.61-2.81],9.056396869037013e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,19301,331,1.53 [1.22-1.92],0.0002791038580087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,16814,295,1.70 [1.18-2.45],0.0041404121790797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,19950,342,1.92 [1.48-2.50],9.586285823132215e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,19885,343,2.01 [1.62-2.48],1.1747175953656924e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,19939,343,1.61 [1.35-1.91],9.634325123627272e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,19668,335,2.27 [1.72-2.99],5.9654534504702304e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,19829,337,1.20 [1.05-1.37],0.0069440346838571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,19888,342,0.53 [0.35-0.81],0.0031271095216567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,19668,335,0.63 [0.46-0.86],0.0035433254495577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,19725,331,1.82 [1.34-2.47],0.0001283904350671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,19742,339,1.41 [1.17-1.70],0.0002821479788607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,19675,335,1.50 [1.07-2.09],0.0173144098527791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,19811,340,2.15 [1.59-2.92],6.900117757031157e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,19911,341,1.40 [1.09-1.80],0.0092498741444957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,19088,318,1.57 [1.08-2.27],0.0184651653249146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,19085,329,1.52 [1.03-2.24],0.0348363620288507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,17124,305,1.81 [1.44-2.28],3.570250835188729e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,19556,336,1.31 [1.07-1.60],0.0092508919239876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,16650,294,1.45 [1.14-1.86],0.0029414379050333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,19752,333,1.61 [1.29-2.02],2.614419606063952e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,19950,342,2.06 [1.59-2.66],3.674462865293992e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,20006,342,1.44 [1.18-1.75],0.0002542052221347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,17199,308,2.52 [1.89-3.35],2.0206768796534844e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,19752,333,2.28 [1.78-2.93],9.138479154409094e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,17141,308,1.61 [1.11-2.33],0.0113994155726633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,19057,326,1.46 [1.06-2.02],0.0209381937534704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,19776,339,2.13 [1.44-3.16],0.0001741843919264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,19592,336,1.75 [1.50-2.04],8.216027033582807e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,19923,342,0.80 [0.68-0.94],0.0056476625716323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,19764,335,1.77 [1.36-2.31],2.383692745302357e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,19668,335,1.31 [1.12-1.53],0.000788769289574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,19764,335,0.59 [0.47-0.76],2.3734924762518413e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,19768,339,1.47 [1.01-2.15],0.0429745795489858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,19800,336,5.92 [3.91-8.95],3.896752578265187e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,17141,308,0.50 [0.43-0.57],1.2694351664270081e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,17141,308,1.51 [1.14-2.00],0.0037700895448642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,19054,325,1.62 [1.42-1.85],9.03699142967994e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,17201,308,1.87 [1.55-2.25],9.169142309133326e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19402,328,1.48 [1.23-1.77],2.34192760805014e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,16677,295,1.40 [1.02-1.91],0.0362585205784722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,19827,337,1.15 [1.03-1.28],0.0138494282451695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,19668,335,1.23 [1.04-1.45],0.0145749740811223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,16916,301,2.18 [1.53-3.09],1.3886941852393491e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,17206,307,1.65 [1.04-2.60],0.0334426476731833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,16233,291,2.75 [1.67-4.54],6.973897506555753e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,16996,303,1.42 [1.08-1.86],0.012844110567346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,17206,307,1.96 [1.11-3.48],0.0207457928910415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,19776,339,1.51 [1.30-1.75],6.781173643646158e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,16735,300,1.53 [1.20-1.95],0.0006706630569148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,19764,335,1.58 [1.27-1.97],4.990481530099008e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17155,308,1.80 [1.44-2.24],2.3401161839449737e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,17140,308,2.24 [1.64-3.06],4.024401733227594e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,17201,308,1.41 [1.27-1.56],2.4564513070831584e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,19353,329,1.55 [1.41-1.72],7.073156263456117e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,19840,337,1.38 [1.00-1.90],0.0496026691698789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,19811,340,2.46 [1.85-3.27],6.738722022018731e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,17201,308,1.61 [1.30-1.99],1.2176701341697422e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,16735,300,1.39 [1.11-1.74],0.0042106128674246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,19903,340,2.13 [1.59-2.85],3.4472634240311294e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,17201,308,1.88 [1.56-2.26],1.858703007009921e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",19677,337,1.26 [1.07-1.47],0.0044581286660276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,19735,334,1.16 [1.01-1.34],0.031092214467778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,19592,336,1.39 [1.05-1.83],0.0206084133617272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,19749,339,1.32 [1.07-1.62],0.0084784041405299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,19776,339,2.00 [1.48-2.69],4.924553105813934e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,19402,328,1.42 [1.06-1.90],0.0187003191101715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,16829,300,0.20 [0.11-0.35],1.3272055503042492e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,19752,333,0.70 [0.53-0.91],0.0087390039862885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,19752,333,1.51 [1.30-1.75],4.318457953035109e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,19695,334,2.53 [1.89-3.39],3.6170182577511054e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,19301,331,1.95 [1.61-2.37],1.2225636810980097e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,16735,300,1.69 [1.37-2.08],7.720831288138768e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,16735,300,1.42 [1.04-1.95],0.027285927185257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,19939,343,2.05 [1.35-3.13],0.0007967411752646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",19565,336,1.13 [1.02-1.26],0.0174787292746771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,19741,338,0.77 [0.68-0.88],0.0001722134077875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,20006,342,1.84 [1.50-2.26],6.276900075644975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,17155,308,2.29 [1.63-3.20],1.4300896011376168e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,19867,338,0.53 [0.45-0.64],4.708220199238812e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,20015,341,0.58 [0.41-0.84],0.0033433470050399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,19776,339,1.56 [1.02-2.37],0.0382799932767132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,19821,342,0.61 [0.46-0.81],0.0005410397271734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,17199,308,1.40 [1.11-1.75],0.00403463181249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,17201,308,1.58 [1.08-2.31],0.0174315931824618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,19854,340,3.51 [2.37-5.19],3.145705866109238e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,20015,341,1.62 [1.07-2.45],0.0219749020784474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,17141,308,1.27 [1.03-1.57],0.0237390008770916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,16735,300,0.80 [0.68-0.93],0.0031819439268607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,17201,308,1.96 [1.21-3.15],0.0057860546636405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,19764,335,2.20 [1.76-2.74],3.00817387579201e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,16814,295,2.09 [1.65-2.63],5.356151744259755e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,20015,341,2.26 [1.79-2.85],7.182622413703508e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,19752,333,1.86 [1.53-2.27],7.974860500734963e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,19740,338,2.78 [2.01-3.84],6.580594515399219e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",16725,292,1.40 [1.10-1.79],0.0065031570077183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",19668,335,1.30 [1.13-1.49],0.0002035369919272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,19896,341,0.80 [0.69-0.92],0.0027849461810867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,19853,342,1.54 [1.17-2.03],0.002179118125404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,19900,343,1.50 [1.17-1.94],0.0017280621138183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,19829,337,1.18 [1.02-1.35],0.0220054330772969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,17199,308,1.76 [1.18-2.61],0.0053073058580649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,19867,338,0.74 [0.60-0.92],0.0055224633196352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,19518,329,1.90 [1.53-2.36],7.0009879302294995e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,16814,295,1.84 [1.37-2.49],5.84343079771137e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,19811,340,1.25 [1.03-1.51],0.0205119320661287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,19266,331,0.78 [0.69-0.88],5.933516798667751e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,19740,338,1.73 [1.22-2.46],0.002286260118294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,19840,341,3.88 [2.48-6.06],2.60884932172443e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,19939,343,0.67 [0.56-0.79],1.548541393765727e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,19220,333,1.18 [1.01-1.37],0.0333324717616514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,20015,341,0.55 [0.40-0.74],0.000119653328548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,17155,308,1.25 [1.11-1.41],0.0001852504738916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,19840,341,3.06 [2.22-4.21],6.795275155240256e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,17214,308,1.83 [1.44-2.32],9.271757623343689e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,19592,336,1.28 [1.09-1.49],0.0023490817354283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,16677,295,1.68 [1.26-2.24],0.0003553906444534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,16677,295,1.47 [1.03-2.09],0.0314736613957769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,19831,337,1.83 [1.34-2.50],0.0001623544757515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,19771,340,1.22 [1.12-1.32],6.097996193376216e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,19510,336,1.59 [1.28-1.96],2.420966044637777e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,17201,308,2.31 [1.58-3.38],1.4604624272935593e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,19776,339,0.79 [0.67-0.93],0.0054153442947553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,19736,338,0.85 [0.73-0.99],0.0328232017321082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,17155,308,0.77 [0.67-0.90],0.0009158159895554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,19788,338,1.30 [1.08-1.56],0.0058084217454514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,19695,338,1.53 [1.23-1.91],0.0001222957820294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,18486,309,1.77 [1.46-2.16],1.3096212341724949e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,19764,335,2.53 [1.73-3.71],1.874233220325844e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,20006,342,1.66 [1.23-2.24],0.0010526639414249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,15560,263,2.34 [1.42-3.86],0.0007998877723029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,19807,338,1.77 [1.31-2.39],0.0002158743262694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,16735,300,1.31 [1.01-1.69],0.0391348209835558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,19752,333,1.95 [1.65-2.31],1.0478876885147796e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,19840,341,1.25 [1.09-1.43],0.001393074766852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,19950,342,1.35 [1.21-1.51],7.853470004835431e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,19413,332,1.61 [1.25-2.06],0.0001987482560258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,19950,342,1.37 [1.21-1.54],4.054686812044251e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,19982,340,3.05 [2.05-4.53],3.284692905364692e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,20006,342,2.13 [1.80-2.52],1.776701100960609e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,19693,335,0.91 [0.84-1.00],0.0436665932520863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,20006,342,0.82 [0.72-0.94],0.0035682775203281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,19630,342,1.24 [1.09-1.41],0.0008041818047311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,19840,341,1.38 [1.21-1.57],1.8962051248554748e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,16962,303,1.40 [1.16-1.68],0.0004554569352451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,17201,308,1.54 [1.02-2.33],0.0420996882133633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,19840,341,1.38 [1.12-1.69],0.0020331171019796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",19829,337,2.14 [1.64-2.80],1.8638019379886442e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,19668,335,0.85 [0.76-0.95],0.0055133320238385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",19668,335,1.66 [1.36-2.03],7.167333209467507e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,19737,335,1.26 [1.03-1.53],0.0223202772495351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,19950,342,2.54 [1.79-3.59],1.6627477972450144e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",19752,333,1.14 [1.03-1.27],0.0148862491033149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,16814,295,1.92 [1.34-2.76],0.0004122077796048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,20015,341,0.73 [0.61-0.86],0.0002551579614811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,19829,337,2.27 [1.69-3.06],6.891599004727616e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,19701,338,0.58 [0.40-0.85],0.005389176821398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,17167,307,1.28 [1.06-1.54],0.0103732324451965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,19803,340,1.29 [1.06-1.57],0.0103468306695581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,19668,335,1.83 [1.32-2.54],0.000293648589053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,19752,333,1.57 [1.25-1.96],8.735369844768414e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,19668,335,0.65 [0.49-0.87],0.0036091574573572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,19614,332,1.56 [1.33-1.81],1.5658500254773972e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,19886,343,1.29 [1.12-1.49],0.000592925559634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,19529,336,1.59 [1.21-2.09],0.0008288208734682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,17102,307,1.56 [1.25-1.94],9.86424243704474e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,19668,335,1.69 [1.19-2.42],0.0037093463494486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,19916,343,1.83 [1.35-2.46],7.863701657101832e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,19332,331,1.34 [1.02-1.76],0.0377558297118022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",17199,308,1.27 [1.11-1.45],0.0003990961822712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",16725,292,1.23 [1.10-1.39],0.0004067602647382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,16602,297,1.32 [1.12-1.55],0.0010194948153115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,19939,343,1.90 [1.52-2.37],1.3204557725661586e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,19752,333,0.76 [0.68-0.85],1.7882464843665308e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,17140,308,0.65 [0.52-0.80],5.525250284889527e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19402,328,2.07 [1.63-2.64],3.991289060246943e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,16725,292,2.46 [1.73-3.50],6.178087094168471e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,19835,337,2.68 [2.03-3.54],4.039439557555554e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,19744,339,1.92 [1.42-2.61],2.86711074393394e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,19556,336,1.76 [1.35-2.31],3.5217843642304106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,19301,331,1.70 [1.33-2.17],2.3377683293919703e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,17141,308,1.54 [1.09-2.16],0.0136405899839055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,20015,341,0.15 [0.08-0.28],9.217555451842795e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,19752,333,1.27 [1.11-1.46],0.0003963744736858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,19764,335,1.27 [1.10-1.47],0.0014693969323602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,17199,308,1.93 [1.44-2.60],1.3114929201966444e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,19413,332,1.30 [1.06-1.60],0.0112182641586131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,20015,341,1.90 [1.08-3.34],0.0255690804093037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,16725,292,0.77 [0.63-0.94],0.0110815008112355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,20015,341,1.89 [1.30-2.74],0.0008723761128308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,19840,341,0.71 [0.59-0.85],0.0002066838189513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,19171,328,1.37 [1.22-1.54],1.458368644765959e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,19301,331,1.31 [1.06-1.61],0.0136213673032261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,19402,328,1.55 [1.04-2.30],0.0311774292291546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,16725,292,1.24 [1.05-1.47],0.0122177186555818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,19735,338,1.12 [1.01-1.25],0.0402858772045585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,19332,331,1.17 [1.02-1.33],0.0204238343187068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,19051,329,2.23 [1.70-2.92],6.548277876048289e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,20015,341,2.16 [1.53-3.06],1.4727770809567368e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,19752,333,1.16 [1.03-1.31],0.0152420155428568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,16725,292,1.23 [1.07-1.43],0.004126117470438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,19909,343,1.79 [1.34-2.38],6.713540528134637e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,19829,337,2.16 [1.48-3.17],7.686728520066829e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,19662,337,1.65 [1.01-2.71],0.0466816202137782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,16595,297,0.50 [0.33-0.76],0.0009340580876797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,17140,308,1.39 [1.02-1.89],0.0388708237262684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,16602,297,0.76 [0.57-1.00],0.0499960673781019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,19950,342,1.59 [1.12-2.26],0.0101598928546294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,19837,338,2.06 [1.19-3.55],0.0095439025387495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",19740,338,1.35 [1.23-1.48],2.3782655910512967e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",19764,335,1.20 [1.07-1.35],0.0020313955825486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",17199,308,1.36 [1.12-1.64],0.0016177104019601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",20015,341,1.59 [1.34-1.89],1.1906565500560161e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,19880,342,1.18 [1.02-1.36],0.0237147071436997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,17199,308,2.34 [1.60-3.42],1.2062268081525826e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,19668,335,1.54 [1.15-2.05],0.0033370316458276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,20006,342,0.67 [0.52-0.86],0.0019302558254838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,17201,308,2.14 [1.54-2.97],4.903498196393177e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",19764,335,1.31 [1.16-1.49],1.6427334542046375e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,19752,333,1.81 [1.48-2.21],7.265389482688665e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,19801,337,1.38 [1.12-1.70],0.0028389578241429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,17185,308,1.76 [1.40-2.21],1.0043934303829967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,19693,336,0.74 [0.59-0.93],0.0096910749907321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,19764,335,0.78 [0.62-0.97],0.0282656924299064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,19776,339,1.26 [1.08-1.48],0.0043961794439292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,19301,331,1.41 [1.24-1.60],1.585970020708313e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",16602,297,1.20 [1.02-1.42],0.0317439842701987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",16602,297,1.33 [1.10-1.61],0.00398403378721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,16821,300,2.28 [1.61-3.23],3.565623010797249e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,16677,295,1.26 [1.03-1.54],0.0246037160721834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,19840,341,1.21 [1.07-1.36],0.0030224112517546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,19752,333,1.16 [1.01-1.33],0.0412911598764244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,19916,343,1.40 [1.30-1.49],1.6887500147013738e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,19904,343,1.38 [1.19-1.60],1.8234232112470488e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,19829,337,0.56 [0.42-0.75],0.0001331170161912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,19829,337,2.98 [2.02-4.40],3.7111863734233584e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,17214,308,2.13 [1.83-2.49],5.81780894798622e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,16602,297,0.76 [0.59-0.99],0.0444538878426435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,19734,339,1.14 [1.00-1.29],0.043054125535356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,19592,336,1.54 [1.21-1.96],0.0004129851375175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,19592,336,1.12 [1.00-1.25],0.0410070234395633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,19592,336,2.00 [1.42-2.82],6.804615590383882e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,19631,335,2.40 [1.61-3.59],1.9847020853759195e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,20006,342,1.67 [1.27-2.20],0.0002248971013221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,17140,308,1.49 [1.10-2.02],0.0099930671743115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,19757,335,1.87 [1.38-2.53],5.056856849388202e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,19950,342,2.17 [1.57-2.99],2.557228971948116e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,16568,296,1.57 [1.17-2.12],0.0027623402005035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,16725,292,1.35 [1.04-1.75],0.0245257823234873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,19811,340,1.43 [1.17-1.74],0.0003678949090752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,16725,292,5.61 [3.58-8.81],6.253269632393237e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,19713,338,3.08 [2.39-3.96],3.5208749909549056e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,16814,295,1.30 [1.10-1.55],0.0025221172841116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,19829,337,1.50 [1.11-2.01],0.0073420929643429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,19950,342,2.03 [1.66-2.49],1.1024212013785309e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",19939,343,1.23 [1.07-1.40],0.0026535762688293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,16725,292,1.24 [1.01-1.52],0.0387837736599266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,19668,335,2.37 [1.70-3.33],4.828690557710984e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,19939,343,0.58 [0.40-0.85],0.0044148414197654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,17199,308,2.77 [1.94-3.96],2.260481758558608e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,19892,340,3.00 [2.06-4.36],9.005274075466462e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,16602,297,0.67 [0.51-0.89],0.0050864031669832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,17155,308,1.31 [1.21-1.40],5.485730594682946e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,17122,307,1.23 [1.04-1.46],0.0180024808477468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,19413,332,1.18 [1.01-1.39],0.0428523162769036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16390,289,1.53 [1.27-1.85],8.493159461595082e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,20015,341,2.29 [1.97-2.66],1.0243662283165068e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,19332,331,1.32 [1.02-1.72],0.0330179570638684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,19301,331,1.25 [1.07-1.45],0.0047690775649693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,19916,343,2.59 [1.91-3.52],1.0178473359351004e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,19668,335,1.81 [1.11-2.95],0.0180637827047319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,16669,292,0.77 [0.64-0.94],0.0093780515251508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,19440,331,1.37 [1.04-1.80],0.0272912332370716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,19744,339,1.82 [1.56-2.12],1.4207787766660836e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,19592,336,3.42 [2.36-4.95],7.285877441295446e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,19737,335,1.10 [1.04-1.16],0.0008987467607495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,16814,295,0.41 [0.28-0.61],1.2630392236233023e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,17155,308,2.04 [1.50-2.77],5.554945753630061e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,18986,323,1.53 [1.05-2.22],0.0273432631079725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,16787,295,1.62 [1.20-2.17],0.0014325001174558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,19592,336,1.31 [1.04-1.65],0.020688628861033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,19402,328,1.53 [1.29-1.82],1.8213226942730485e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,16786,300,1.72 [1.39-2.15],1.0849470558068358e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,20006,342,0.81 [0.66-0.99],0.0414798482093992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,19950,342,2.25 [1.55-3.26],1.922795206094807e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",17201,308,1.34 [1.06-1.69],0.0130053939370233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,19939,343,0.59 [0.42-0.83],0.0022496940079651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,19592,336,0.64 [0.53-0.76],9.613159278770222e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,17140,308,1.31 [1.07-1.59],0.0075799626817781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,17141,308,1.29 [1.08-1.54],0.00524876491924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,19402,328,1.34 [1.15-1.56],0.0002104680605679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,17140,308,1.45 [1.22-1.71],1.4862726975220268e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,19673,336,1.96 [1.38-2.79],0.0001712836383983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",19668,335,1.68 [1.47-1.92],4.857389376347047e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,17144,308,0.36 [0.21-0.62],0.0002623945071407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,19672,338,1.32 [1.01-1.74],0.043629428911728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,19854,339,1.49 [1.28-1.75],6.381400771388105e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,19939,343,1.10 [1.01-1.19],0.0206573199705822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,19911,341,1.73 [1.52-1.96],1.3812452237729085e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,19776,339,2.07 [1.62-2.66],8.977719357021849e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,16814,295,2.78 [1.88-4.11],3.21106411874982e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,17199,308,1.71 [1.10-2.64],0.0163961151319196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,20006,342,2.71 [2.16-3.39],4.363208392660563e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,17121,307,1.43 [1.18-1.73],0.0002063741914972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",19691,330,1.36 [1.04-1.78],0.0260401788187259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",19752,333,1.90 [1.40-2.59],4.724703454353002e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",16725,292,1.31 [1.05-1.64],0.0187453961970071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,19332,331,1.30 [1.08-1.58],0.0069633040621814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,19506,336,1.35 [1.11-1.65],0.0029718535533177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,17167,307,1.28 [1.04-1.57],0.0207528245727299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,19301,331,0.48 [0.36-0.63],1.429494368207256e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,16991,306,1.16 [1.03-1.31],0.0153493708603483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,19752,333,1.67 [1.31-2.13],2.8330223384961124e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,19635,332,2.24 [1.64-3.06],3.313758831246536e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",19829,337,1.26 [1.07-1.47],0.0048867564744651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,19686,335,3.26 [2.20-4.82],3.5432400624598582e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,19695,335,3.71 [2.80-4.92],6.973375208370703e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,20015,341,1.51 [1.11-2.06],0.0092995866856785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,20015,341,1.99 [1.42-2.79],6.873485085599311e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,19764,335,2.35 [1.90-2.92],7.963308762946278e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,19668,335,0.55 [0.33-0.92],0.022953674334563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,19939,343,1.56 [1.26-1.93],5.137166961789377e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,16730,300,2.38 [1.88-3.02],6.853738399248126e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,19413,332,1.10 [1.01-1.20],0.0310905655126171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,19840,341,1.68 [1.10-2.55],0.0155440745553144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,19592,336,1.37 [1.14-1.64],0.0006625095520989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,19668,335,1.69 [1.09-2.63],0.0192514780798588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,19776,339,2.44 [1.64-3.61],9.254686967832378e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,19985,341,1.34 [1.24-1.45],3.9973558196711384e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,19988,341,1.72 [1.47-2.02],2.562781723543621e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,19867,338,0.36 [0.28-0.46],1.129641878893265e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,19530,336,1.78 [1.48-2.14],9.580763764224712e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,20015,341,2.60 [2.07-3.28],4.651100386537242e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,19764,335,2.82 [2.20-3.62],3.225208005780733e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,17187,306,2.40 [1.84-3.13],1.3664722217511628e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,19668,335,1.78 [1.45-2.18],3.736565585404138e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,19764,335,1.74 [1.30-2.35],0.0002413247064267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,17199,308,1.29 [1.14-1.45],4.263966867913008e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,19840,341,2.55 [1.94-3.37],3.5007115479422806e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,19413,332,1.33 [1.01-1.75],0.0404301977051077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,19752,333,2.43 [1.84-3.21],4.030377840081965e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,19413,332,1.43 [1.07-1.91],0.0158889370869045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,19370,331,1.29 [1.07-1.56],0.0086631581726764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,19413,332,1.34 [1.18-1.53],6.97214737934045e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,19504,329,0.81 [0.67-0.98],0.0289349062338057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,19673,336,1.79 [1.45-2.20],5.164367819215883e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,19867,338,2.53 [1.92-3.34],5.5347224385924955e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,20006,342,1.54 [1.16-2.04],0.0026140443889028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,19269,329,1.50 [1.34-1.69],4.661941856607088e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,19315,329,1.27 [1.09-1.48],0.0017484805701717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,19744,339,2.09 [1.41-3.08],0.0002264974651344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,19776,339,0.56 [0.44-0.72],3.01191034740018e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,19945,340,2.14 [1.75-2.63],3.04683179102516e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,19413,332,0.36 [0.28-0.47],7.0727516663846e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,19699,339,1.56 [1.34-1.81],6.022191762477085e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,16677,295,0.72 [0.54-0.96],0.0250641213692283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,17140,308,1.57 [1.36-1.80],4.594631513781533e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,19630,336,2.31 [1.86-2.86],2.2993143111051102e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,19752,333,1.57 [1.29-1.91],6.136946333188246e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,19300,328,1.36 [1.02-1.83],0.0389807915101081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,16677,295,1.27 [1.08-1.50],0.0042937966766224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,16624,295,1.21 [1.05-1.41],0.011039775031832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,19752,333,2.11 [1.69-2.64],6.395355298920328e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,19668,335,1.56 [1.42-1.72],8.558274129024152e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,19764,335,3.38 [1.97-5.81],1.0633285581338787e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,19776,339,0.79 [0.66-0.95],0.0108716175012221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,17140,308,1.56 [1.25-1.94],8.426428210324442e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,16814,295,1.72 [1.41-2.09],6.114858284305331e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,17155,308,0.66 [0.58-0.74],2.4267464640972124e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,17141,308,1.14 [1.02-1.27],0.020620557342497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,16677,295,3.72 [2.01-6.90],2.9842419283082344e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,19752,333,1.32 [1.02-1.69],0.0328617777105288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,19752,333,0.59 [0.44-0.78],0.0003155102389543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,16814,295,0.69 [0.49-0.97],0.0332219078261063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,19776,339,3.17 [2.19-4.59],1.0368924154687995e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,16677,295,1.47 [1.11-1.95],0.0071472179383928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,19776,339,0.68 [0.50-0.93],0.017140246361598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,19939,343,0.30 [0.17-0.52],1.6607897587666657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,16895,301,1.25 [1.03-1.53],0.0259077168354608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,19939,343,1.37 [1.12-1.67],0.002156811402018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,17201,308,2.15 [1.71-2.72],8.926065791407451e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,19867,338,2.53 [1.95-3.29],3.505078929119548e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,17206,307,1.84 [1.25-2.71],0.0021156514039335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,17140,308,1.28 [1.00-1.64],0.0468819693789642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,19413,332,1.42 [1.21-1.68],2.2148851084012566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,19668,335,0.81 [0.65-1.00],0.0475339113288399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,17140,308,1.15 [1.01-1.31],0.0303113396516715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,16595,297,1.16 [1.03-1.30],0.0135706194712293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,19837,338,0.49 [0.35-0.68],2.152234197077663e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,19764,335,0.48 [0.38-0.61],1.449622522882301e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,16636,304,1.44 [1.12-1.86],0.0043320997363564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,19603,331,1.09 [1.01-1.17],0.0237326130842271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,19780,335,1.79 [1.45-2.22],7.487859366536403e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,19641,335,1.79 [1.40-2.29],3.951453536532958e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,19939,343,1.30 [1.07-1.60],0.0101411774665752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,17201,308,0.79 [0.71-0.88],3.1487988134162465e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,19939,343,1.43 [1.24-1.63],3.375281518559992e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,19110,324,1.58 [1.21-2.08],0.0009350494525677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",19668,335,1.21 [1.08-1.34],0.0006920960037824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",19716,332,1.22 [1.07-1.40],0.0030081397539493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",16636,304,1.21 [1.07-1.36],0.0015687314781188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,20006,342,1.26 [1.02-1.55],0.0298673702382501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,17199,308,1.15 [1.01-1.30],0.0325927906971718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,19740,338,1.73 [1.41-2.13],1.6081549374839224e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,19840,341,1.60 [1.22-2.11],0.0007302335276176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,16725,301,1.73 [1.34-2.22],1.982892795157352e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,19158,330,1.70 [1.03-2.81],0.0392592331591514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,19972,341,1.84 [1.56-2.18],8.956532314067217e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,19565,336,1.89 [1.47-2.43],5.478811665587248e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,19867,338,1.45 [1.23-1.71],1.1184345136916158e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,19950,342,1.19 [1.05-1.35],0.0079721645862594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,17214,308,0.35 [0.22-0.57],2.4514609274108263e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,19172,323,1.40 [1.11-1.75],0.0040400315186958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,19823,337,0.73 [0.60-0.88],0.0011854568453442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,17199,308,1.28 [1.09-1.50],0.0029922712274127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,16262,282,1.36 [1.16-1.59],9.979950892786574e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,17167,307,1.67 [1.24-2.24],0.0007025241260375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,19764,335,2.05 [1.54-2.71],6.006700424287515e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,17167,307,1.36 [1.12-1.65],0.0017700060083065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,19828,340,1.73 [1.26-2.38],0.0006735380391386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,17206,307,2.55 [1.90-3.42],3.6457886929799454e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,19740,338,1.94 [1.66-2.27],1.10920748275262e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,19715,340,1.31 [1.06-1.61],0.0119668546210084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,19742,339,2.36 [1.78-3.12],1.771316315743986e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,19840,341,2.30 [1.78-2.97],2.3744913455318636e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,19332,331,1.25 [1.03-1.50],0.0225215123191186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,19752,333,2.91 [2.03-4.18],7.250222896012421e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,19776,339,1.79 [1.35-2.39],6.848900433960803e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,19737,335,2.36 [1.75-3.17],1.3931313721367637e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,17199,308,1.25 [1.07-1.46],0.0050953870236574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,20015,341,1.75 [1.22-2.50],0.0023678596303499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,19918,340,1.72 [1.28-2.33],0.0003950867910606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,19413,332,1.39 [1.12-1.74],0.0032766519483885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,17155,308,1.65 [1.15-2.36],0.0066181629806363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,17167,307,1.54 [1.17-2.02],0.0023059566162998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",16725,292,1.20 [1.05-1.36],0.0057166784492899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,19064,330,1.29 [1.10-1.52],0.0017990909544743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,16602,297,1.21 [1.03-1.42],0.0233530021687021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,17206,307,3.23 [2.19-4.75],2.798817370092727e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,19888,341,1.33 [1.02-1.74],0.0360269795286658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,19668,335,1.74 [1.23-2.45],0.0018259180110536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,19950,342,1.20 [1.03-1.40],0.0176869596571298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,19668,335,1.85 [1.49-2.31],2.903126467345893e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,19413,332,0.45 [0.35-0.58],1.3581124435247426e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,20015,341,2.54 [1.96-3.29],1.768768626483433e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,19301,331,1.49 [1.27-1.74],6.512098928964297e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,19634,336,2.25 [1.66-3.05],1.717801398686459e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,19635,337,1.31 [1.03-1.67],0.0255299825534977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,19539,332,1.89 [1.39-2.57],5.352939839752168e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,19592,336,2.53 [2.01-3.18],2.2001492153687438e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,17206,307,3.74 [2.12-6.62],5.785916912239063e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,16595,297,0.45 [0.31-0.66],3.913292466923591e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,16725,292,1.31 [1.00-1.72],0.0479822186698857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,17199,308,1.55 [1.14-2.09],0.0045152981827106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",16595,297,1.31 [1.05-1.64],0.0164407155030775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,19829,337,1.66 [1.17-2.35],0.0043765680515434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,19764,335,2.07 [1.41-3.04],0.0002168649883012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,19565,336,0.63 [0.41-0.96],0.0338005818167466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,19768,339,3.04 [2.22-4.16],4.2933202756498734e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,16974,304,1.16 [1.04-1.29],0.0056811211125208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,16677,295,1.17 [1.03-1.33],0.0165621900775187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,19664,334,1.32 [1.06-1.64],0.0137757970190621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,19769,335,1.70 [1.45-2.00],8.550862928960055e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",16725,292,1.18 [1.05-1.34],0.0070373739607422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,19740,338,1.33 [1.03-1.72],0.027345269854117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,16814,295,0.47 [0.29-0.76],0.0021901900893756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,19764,335,0.75 [0.69-0.82],5.477943377781525e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,19740,338,0.52 [0.36-0.75],0.0005897937110864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,20006,342,1.70 [1.17-2.48],0.0055042181593998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",19752,333,1.18 [1.05-1.33],0.0062559977495278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,16814,295,1.61 [1.15-2.24],0.0052445190449332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,19776,339,1.45 [1.18-1.79],0.0005196239545942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,19829,337,0.75 [0.57-0.99],0.0428640561700063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,19752,333,1.20 [1.09-1.31],9.294746876687975e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,19413,332,1.47 [1.22-1.76],3.844103857459701e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,19668,335,1.19 [1.06-1.35],0.0045752757327079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,19100,320,1.27 [1.12-1.43],0.0001160129609799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,19700,337,1.39 [1.18-1.63],8.620619015179925e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,19805,340,2.05 [1.75-2.40],6.575690723799042e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,19332,331,1.39 [1.00-1.93],0.0490161301767078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,19374,327,2.15 [1.73-2.66],3.502007639419341e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,19917,341,1.50 [1.33-1.70],7.651542868933229e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,19748,339,1.64 [1.40-1.93],1.8840405907962072e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,19939,343,0.69 [0.52-0.92],0.0117624295332727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,19776,339,1.40 [1.15-1.70],0.0007111642131001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,17214,308,4.79 [3.37-6.80],2.0798598079442494e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",19332,331,1.48 [1.07-2.05],0.0181534870872711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",17167,307,1.22 [1.06-1.40],0.0055307612707726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,19633,335,1.60 [1.39-1.83],4.188532676994738e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,16735,300,1.34 [1.01-1.77],0.0415212719189245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,19950,342,2.13 [1.75-2.59],3.8668935347852864e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,19402,328,0.58 [0.48-0.69],2.15453762124537e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",17155,308,1.71 [1.18-2.48],0.0042629330459663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",17141,308,1.17 [1.03-1.33],0.0131635112131003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,16895,301,1.28 [1.06-1.53],0.0089901698490364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,19332,331,1.29 [1.08-1.54],0.0053950491459549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,19413,332,1.37 [1.23-1.53],2.4224859938061386e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,16595,297,1.35 [1.06-1.71],0.016233893846399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,16725,292,0.84 [0.72-0.98],0.0271171538946076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,19797,340,2.02 [1.70-2.40],1.0630808657066797e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,16814,295,2.06 [1.22-3.47],0.006669043941164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,19301,331,1.19 [1.01-1.39],0.0370802619229942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,19829,337,1.98 [1.40-2.80],0.0001086542072761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,19867,338,0.71 [0.52-0.96],0.0277769527722028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,19950,342,0.57 [0.44-0.74],1.3979202387640207e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,19709,332,1.16 [1.04-1.29],0.006282701812982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,17141,308,1.77 [1.33-2.36],0.0001022463449599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,16602,297,1.31 [1.01-1.69],0.0442666387246933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,19737,335,2.13 [1.60-2.83],2.444461839438495e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,19829,337,1.68 [1.30-2.18],8.735731707284259e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,19277,329,1.58 [1.31-1.92],2.961505392156977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,20006,342,2.08 [1.52-2.83],3.874163204553916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",19413,332,1.52 [1.32-1.76],9.489439244271609e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",17141,308,1.14 [1.03-1.28],0.0140040344987139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,16419,291,2.74 [1.91-3.94],4.719833083743723e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,19802,337,1.37 [1.05-1.79],0.0199141602617594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,16725,292,0.72 [0.55-0.93],0.0128531094839805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,19768,339,2.54 [1.83-3.53],2.8365528324155825e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,17069,306,1.19 [1.02-1.39],0.0241158542189098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",19332,331,1.44 [1.23-1.69],4.329944485428329e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,20015,341,1.55 [1.18-2.04],0.0016510503226259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,16910,302,2.41 [1.86-3.11],1.558122005601016e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,19764,335,1.70 [1.32-2.19],4.400689056327498e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,17199,308,1.40 [1.11-1.76],0.0044252711335618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,19402,328,1.12 [1.04-1.21],0.003419089096298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,19776,339,1.62 [1.30-2.00],1.0673626641292144e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,17201,308,1.79 [1.29-2.49],0.0005111544680401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,19764,335,0.64 [0.47-0.87],0.0039825339191468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,19939,343,0.78 [0.67-0.90],0.0007920407950308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,17167,307,1.36 [1.07-1.72],0.0118585769604949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,19900,338,2.58 [1.82-3.67],1.2100374481755725e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,19776,339,1.47 [1.05-2.05],0.0251334009218157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,17155,308,2.19 [1.69-2.85],3.4334052524887393e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,19829,337,1.30 [1.09-1.55],0.0039130659322628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,19950,342,0.52 [0.33-0.81],0.0041454743660981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,19764,335,1.27 [1.17-1.38],3.366177274494053e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,19909,343,1.31 [1.02-1.69],0.0357191804118389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,17111,307,1.16 [1.02-1.32],0.020488325215796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,19776,339,1.27 [1.05-1.55],0.0162286188632537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,19527,336,0.78 [0.66-0.93],0.0059726919434623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,17167,307,2.37 [1.95-2.89],9.10708278202218e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,19300,328,0.76 [0.62-0.93],0.0071502574456229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,19776,339,1.34 [1.07-1.67],0.0096485082175798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,16203,287,1.21 [1.10-1.33],0.0001436049728961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,19565,332,1.38 [1.20-1.59],5.348867141770778e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,19668,335,0.71 [0.61-0.82],2.6582755755569627e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,17145,307,2.82 [1.68-4.76],9.75278841441618e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,19768,339,2.80 [2.09-3.74],3.1898361486779047e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,19652,331,1.54 [1.34-1.76],4.6035144423234924e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,19900,338,6.25 [3.91-10.01],2.1637529532878075e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,19950,342,1.08 [1.01-1.16],0.0210789464955905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,19682,334,1.44 [1.12-1.84],0.004762308453212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,17155,308,2.23 [1.76-2.82],1.900324309996861e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,17167,307,1.82 [1.16-2.83],0.0084287443097477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,17140,308,1.40 [1.06-1.84],0.0183655730939872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,20015,341,1.67 [1.31-2.13],3.543496611660687e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,19668,335,1.52 [1.11-2.07],0.0081604554658782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,19950,342,1.22 [1.03-1.44],0.0216405441949847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,19764,335,1.40 [1.00-1.96],0.0476224772727556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,16595,297,1.21 [1.02-1.42],0.0250970896576295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,16602,297,1.25 [1.04-1.50],0.0166536596338102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,16677,295,1.56 [1.26-1.92],3.571131316797085e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,19776,339,1.67 [1.21-2.30],0.0016931307161625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,16677,295,1.11 [1.01-1.21],0.0324337500556071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,17214,308,1.40 [1.20-1.62],1.37121690775158e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,20006,342,2.18 [1.58-3.01],2.151989404465113e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,19918,340,1.35 [1.09-1.67],0.0056759054759425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,17141,308,1.40 [1.14-1.72],0.0013521433415147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,19516,337,1.57 [1.34-1.83],1.3562195777901564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,19515,335,4.03 [3.22-5.03],1.4444769626587914e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,19752,333,1.19 [1.02-1.40],0.0276681014550083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,19776,339,1.56 [1.14-2.14],0.0059593091249553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,19776,339,2.15 [1.71-2.72],8.753393189281129e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,19764,335,1.59 [1.33-1.92],6.866448239580579e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,17199,308,2.67 [1.78-4.02],2.160966307926063e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,19592,336,1.20 [1.01-1.43],0.0378213675178247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,19829,337,4.84 [3.53-6.64],1.7236733303786726e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,19987,341,0.61 [0.50-0.76],4.654890859859306e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",19744,337,1.43 [1.23-1.65],1.3395359364239895e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,19776,339,0.45 [0.33-0.60],6.902079692256247e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,19945,340,1.66 [1.38-2.00],1.0924168519068157e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,19776,339,2.48 [1.91-3.23],1.2897430447525354e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,19605,336,5.50 [4.17-7.26],2.044506624689985e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,16784,300,2.23 [1.35-3.66],0.0015882625216165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,19961,341,1.31 [1.01-1.69],0.0413094040983737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,19301,331,0.53 [0.36-0.78],0.0013010642298054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,17155,308,1.67 [1.16-2.41],0.0059464599764466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,19913,340,2.40 [1.66-3.48],3.7921670269599487e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,16735,300,1.35 [1.10-1.67],0.0040361462556541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,17214,308,0.82 [0.70-0.97],0.0206077655466026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",19413,332,1.10 [1.01-1.20],0.0256385661313539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,16677,295,1.51 [1.19-1.91],0.0006341250958149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",19668,335,1.33 [1.05-1.66],0.0156978492101231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,16725,292,0.80 [0.68-0.94],0.0059859432865824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,19402,328,1.55 [1.17-2.06],0.0025651959154637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,19840,341,0.71 [0.54-0.93],0.0134691609798332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",17201,308,1.22 [1.03-1.44],0.0193356231980366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,17167,307,1.54 [1.20-1.98],0.0007593814517009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,17201,308,1.99 [1.48-2.69],6.0506797587078985e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,17140,308,1.25 [1.01-1.56],0.0414879433962731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,19896,340,1.56 [1.15-2.11],0.0038083634258852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",19413,332,1.24 [1.08-1.42],0.0016868465345067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,19413,332,1.41 [1.01-1.95],0.0425215677960724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,17201,308,1.45 [1.17-1.79],0.0006764156671863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,17201,308,1.40 [1.12-1.76],0.0032121351487489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,17155,308,1.49 [1.21-1.83],0.0001771651914124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,19837,338,0.56 [0.39-0.82],0.0025600335730551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,19752,333,0.79 [0.64-0.97],0.0249479267157103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,19867,338,1.22 [1.04-1.44],0.0153029155095394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,16677,295,2.19 [1.74-2.76],3.919618477725466e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,17155,308,1.54 [1.15-2.05],0.0032698849813819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,19670,339,2.80 [2.27-3.45],5.084145145421796e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,19939,343,2.63 [1.87-3.71],3.2064899065084834e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,19286,327,1.20 [1.00-1.44],0.0496966576491446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,16895,301,1.42 [1.01-2.00],0.0452942221985262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,17043,304,2.76 [2.02-3.76],1.5526812914807176e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,19592,336,1.21 [1.10-1.34],0.0001502138080856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,19301,331,1.22 [1.03-1.43],0.0203683930279351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,17199,308,1.14 [1.00-1.30],0.0445797181434504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,19332,331,1.86 [1.42-2.44],7.79558890791336e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,19402,328,1.77 [1.48-2.13],9.956655489890434e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,16677,295,1.29 [1.04-1.59],0.0191537941550742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,17199,308,1.71 [1.19-2.46],0.0036488863124765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,17201,308,1.95 [1.23-3.08],0.0042844159356402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,17141,308,2.32 [1.53-3.53],7.814193917739037e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,17155,308,0.67 [0.50-0.90],0.0079149836644592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,20015,341,0.64 [0.43-0.95],0.0275726505557138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,17199,308,1.80 [1.26-2.57],0.0011870012877213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,19235,327,1.22 [1.02-1.45],0.0252686327885767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,19752,333,1.55 [1.23-1.95],0.0001682224942819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,19950,342,2.31 [1.85-2.89],1.2041998795319733e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,19788,339,1.76 [1.23-2.53],0.00211526380353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,16874,303,1.47 [1.20-1.80],0.0002139071390908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,19752,333,0.68 [0.54-0.85],0.000717653264275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,19332,331,1.22 [1.01-1.49],0.043915877894428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,19301,331,1.26 [1.07-1.49],0.0046266781489398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,19900,338,1.42 [1.18-1.70],0.0001417791223178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,19301,331,1.17 [1.01-1.36],0.0336382013720358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,17167,307,1.79 [1.44-2.21],9.161890711504173e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,19309,329,1.26 [1.03-1.54],0.0252601548772722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,19668,335,1.33 [1.18-1.50],5.063350143095426e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,19668,335,1.27 [1.07-1.49],0.0056533913048632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,17141,308,1.31 [1.13-1.53],0.0004705807401915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,19671,336,1.35 [1.13-1.62],0.0010276632265735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,20015,341,1.19 [1.01-1.40],0.0335611794036245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,20015,341,1.26 [1.09-1.45],0.001495733818577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,19768,339,1.38 [1.15-1.67],0.0005958980936698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,16677,295,1.45 [1.20-1.76],0.0001372417251172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,19776,339,1.40 [1.02-1.92],0.0360353757588678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,19764,335,1.48 [1.33-1.65],3.847903391065256e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,19668,335,0.63 [0.48-0.82],0.0006001950997754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,19730,335,1.28 [1.04-1.59],0.0211923444943702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,19950,342,0.66 [0.49-0.91],0.010274591281854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,16787,294,0.72 [0.57-0.92],0.0088194893411054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,17214,308,2.59 [1.81-3.71],2.1036027981646802e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,16664,295,2.41 [1.71-3.40],5.214693102936637e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,17101,307,2.03 [1.62-2.53],5.837690598391185e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,19929,340,2.76 [1.97-3.84],2.455713724112046e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,16725,292,2.42 [1.76-3.34],6.711295672388788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,19768,339,2.29 [1.56-3.34],2.0715476621583344e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,19668,335,1.27 [1.02-1.60],0.033957626563373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,19301,331,1.33 [1.12-1.60],0.0014966525775677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,16636,304,1.17 [1.03-1.31],0.0118607904126942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,19592,336,1.85 [1.41-2.42],6.8076246622041465e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,19939,343,1.51 [1.09-2.09],0.014422706767388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,16602,297,1.28 [1.05-1.55],0.0127156393239483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,19939,343,0.63 [0.47-0.85],0.0020413856847347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,19611,331,1.35 [1.14-1.60],0.0005871230719081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,19465,330,1.21 [1.05-1.38],0.0068042056493664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,17167,307,1.36 [1.11-1.67],0.0026417028380915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,19300,328,1.25 [1.07-1.47],0.0050701990065029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,17167,307,1.33 [1.08-1.63],0.0078556965312342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,17170,308,1.57 [1.15-2.15],0.0048950870135706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,19213,327,1.59 [1.21-2.09],0.001024697493134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,20015,341,1.44 [1.15-1.80],0.0014443246133438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,19950,342,2.44 [1.76-3.39],9.652761101413341e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,19772,339,0.62 [0.53-0.73],2.515799861876877e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,16814,295,1.79 [1.18-2.72],0.0064448731076619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,19811,340,1.25 [1.13-1.39],2.0830197043885205e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,19888,341,1.43 [1.18-1.73],0.0002383362906715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,19301,331,1.23 [1.09-1.39],0.0009220642281047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,16665,292,1.34 [1.08-1.67],0.0089283599296512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,16735,300,0.58 [0.45-0.74],2.2781706978886096e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,19764,335,1.44 [1.16-1.80],0.0011325496633895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,17141,308,1.26 [1.08-1.47],0.0041159220966019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,16725,292,1.62 [1.25-2.11],0.0002884793196096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,20015,341,1.48 [1.21-1.80],0.000132760747751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,17206,307,0.28 [0.17-0.46],4.260913030671123e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,19752,333,1.60 [1.14-2.24],0.0069532143403154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,17167,307,1.32 [1.15-1.51],7.580205368591032e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,17124,306,2.13 [1.61-2.82],1.3455062138441338e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,16899,304,6.89 [2.49-19.06],0.0002012155357188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,20015,341,1.96 [1.54-2.49],5.053456875263196e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,19191,324,0.90 [0.81-1.00],0.0421715483683047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,17158,306,4.48 [2.56-7.82],1.4024669277372414e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,16912,303,0.37 [0.23-0.59],3.000768065140031e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,16966,304,0.60 [0.40-0.89],0.0111595285704416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,17206,307,3.12 [1.58-6.17],0.0010749972613704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,19585,334,1.19 [1.04-1.35],0.0111202794990484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,17178,306,0.32 [0.15-0.68],0.0029754934457895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,17178,306,2.02 [1.36-2.99],0.0004481761984679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,20015,341,1.19 [1.02-1.39],0.0226084174259708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,16946,305,1.63 [1.06-2.50],0.0245802256671823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,16894,304,0.39 [0.17-0.93],0.0328752284926905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,17178,306,3.36 [1.84-6.12],7.523102600082829e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,16787,295,1.51 [1.05-2.17],0.0248994055280707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,19668,335,2.18 [1.54-3.08],1.2070826421032549e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,19522,335,1.55 [1.27-1.88],1.089459376391714e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,19301,331,1.38 [1.19-1.59],2.19873469426657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,19301,331,1.42 [1.21-1.66],1.3566687201000096e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,16934,305,1.31 [1.08-1.59],0.0070880970241983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,17214,308,1.85 [1.44-2.37],1.480782338779518e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,17201,308,2.58 [1.92-3.48],4.54456538740861e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,19793,337,1.62 [1.32-1.99],5.044131965918879e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,19840,341,2.14 [1.73-2.65],2.0349124347122968e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,19752,333,1.92 [1.49-2.47],5.134286809256103e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,19764,335,1.97 [1.39-2.79],0.0001414405203212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,19911,341,1.74 [1.26-2.41],0.000736910918157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,19823,339,1.22 [1.01-1.46],0.0340876563921079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,19703,337,1.48 [1.21-1.82],0.000166152367044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,19413,332,1.21 [1.01-1.44],0.0335343276913824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,19413,332,1.45 [1.22-1.72],1.929278352280436e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,19301,331,1.46 [1.14-1.86],0.002778268741774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,19752,333,1.64 [1.41-1.91],1.9150585743305343e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,19301,331,1.62 [1.33-1.96],1.100431634232891e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,16602,297,1.61 [1.07-2.43],0.0233328566960668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,19332,331,1.38 [1.19-1.61],2.457287972164322e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,16595,297,0.74 [0.56-0.98],0.0325542125191452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,19332,331,1.39 [1.17-1.65],0.0001509692110174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,16677,295,0.57 [0.40-0.81],0.0017908334422604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,19939,343,0.71 [0.56-0.90],0.0042183430223813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,19402,328,0.73 [0.55-0.99],0.0400214087473134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,19840,341,1.80 [1.42-2.29],1.5364802336395529e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,19859,340,1.73 [1.45-2.05],6.477285838325531e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,19803,340,1.17 [1.01-1.36],0.0337107746263473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,17120,307,1.13 [1.01-1.28],0.0411156598093558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",16725,292,1.64 [1.19-2.27],0.002769463803317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",19776,339,2.07 [1.67-2.58],6.559066878129148e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,17167,307,1.45 [1.16-1.81],0.0010938781266711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,19301,331,1.44 [1.10-1.88],0.0085051788947402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,19737,335,0.71 [0.55-0.92],0.0092648794170719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,17199,308,1.44 [1.04-2.00],0.0303920172977208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,19776,339,1.72 [1.41-2.10],9.350159540197465e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,19752,333,1.16 [1.00-1.34],0.0482822032326118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,19703,338,3.00 [2.25-4.00],6.180637796613354e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,19840,341,1.34 [1.05-1.71],0.0189178120622257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,17141,308,0.91 [0.85-0.97],0.0050461896764995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,19768,339,2.66 [2.04-3.46],3.108694064358828e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,19670,335,2.46 [1.90-3.19],1.0538981739529104e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,19988,341,1.58 [1.29-1.95],1.1529414925884662e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,17155,308,1.23 [1.04-1.47],0.0172787657326336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,17199,308,1.74 [1.28-2.37],0.0003824510629939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,19737,335,0.67 [0.62-0.74],2.618651798506961e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,17141,308,1.24 [1.00-1.53],0.0471001749380651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",19668,335,1.30 [1.04-1.62],0.0210507086635097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20015,341,2.30 [1.74-3.04],4.199211088667666e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,17201,308,2.11 [1.41-3.15],0.0002690998428721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,19950,342,1.29 [1.05-1.58],0.0157018535237517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,19752,333,1.48 [1.30-1.69],2.0198178306464543e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,19776,339,2.43 [1.85-3.20],2.503110852519341e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,16735,293,0.64 [0.46-0.89],0.0083121680249769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,17519,306,1.90 [1.37-2.65],0.0001247671158535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,19668,335,1.42 [1.10-1.83],0.0070969901441343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,16883,303,1.89 [1.47-2.42],4.689076830620955e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,19988,341,2.10 [1.59-2.78],1.9650447287397938e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,17199,308,1.39 [1.03-1.88],0.0305491901141414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,17199,308,2.28 [1.60-3.25],5.746349736745066e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",16735,300,1.46 [1.16-1.84],0.0013335038105853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,19829,337,1.63 [1.04-2.54],0.0317306226707388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,16735,300,0.72 [0.59-0.89],0.0017649237470362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,19683,336,1.46 [1.31-1.62],3.1916978369628688e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,19811,340,2.10 [1.83-2.42],2.2903691669104878e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,19774,335,1.89 [1.56-2.29],1.3198609213298742e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,19776,335,1.58 [1.34-1.86],4.94924068059957e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,17140,308,0.87 [0.78-0.98],0.0246526269394019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,19752,333,1.99 [1.67-2.38],2.9751261958324263e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,19972,341,1.90 [1.51-2.40],5.917455320537621e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,19671,335,1.62 [1.12-2.35],0.0100690107219897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,19829,337,1.85 [1.44-2.37],1.637695186621359e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,20015,341,1.48 [1.07-2.04],0.0177404087617472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,17214,308,1.71 [1.13-2.60],0.0115996745416208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,19776,339,2.57 [2.11-3.13],8.721354001314821e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,19802,337,1.53 [1.24-1.88],6.810659724342037e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,19950,342,1.43 [1.03-1.98],0.0309049912701598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,20015,341,1.43 [1.09-1.87],0.0098552592436817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",19305,331,1.30 [1.06-1.59],0.0125182195889874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,19867,338,1.50 [1.20-1.87],0.0003351639118984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,19580,332,2.81 [2.14-3.69],1.3030812963232657e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,17199,308,1.43 [1.06-1.94],0.0207993012074531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,19840,341,1.12 [1.04-1.21],0.0019047404409238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,19776,339,2.41 [1.95-2.99],9.45214320034971e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,16636,304,1.33 [1.04-1.70],0.021991486372081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,16677,295,1.65 [1.12-2.44],0.0112197045059938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,16725,292,1.32 [1.10-1.59],0.0024732756641783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,17124,306,1.87 [1.44-2.45],3.8703253523126615e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,19776,339,1.14 [1.00-1.30],0.0461782850990041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,19867,338,1.78 [1.46-2.15],6.10514539762079e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,19380,328,1.47 [1.17-1.86],0.0010395112862583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,17141,308,1.28 [1.05-1.57],0.0137645505204415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,19592,336,2.61 [2.06-3.31],1.5994058117915485e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,19592,336,1.61 [1.41-1.83],1.300009953103379e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,19837,339,1.43 [1.16-1.77],0.0006999655556516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20006,342,1.60 [1.27-2.00],5.483825922782254e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,19740,338,3.39 [2.54-4.53],1.6390434664745178e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,19829,337,2.07 [1.64-2.63],1.7703024177480122e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,19768,339,1.32 [1.03-1.68],0.0253981892651597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,19768,339,1.97 [1.48-2.62],3.386371766213919e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,16814,295,1.40 [1.07-1.83],0.0141830618607018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,19776,339,2.48 [1.88-3.25],7.447663846298866e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,19776,339,1.85 [1.54-2.23],4.779856405958408e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,19950,342,1.88 [1.35-2.63],0.0001890904223392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,19972,341,1.66 [1.30-2.10],3.6315951811799455e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,19592,336,1.56 [1.34-1.82],6.071606211987133e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,19592,336,1.43 [1.17-1.75],0.0003822512506166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,20006,342,0.52 [0.36-0.76],0.0006401313890287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,19752,333,0.72 [0.62-0.85],8.029678570218921e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,20006,342,0.47 [0.33-0.67],2.626280725665889e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,19840,341,2.37 [1.68-3.33],7.281125693595345e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,19982,340,2.54 [1.92-3.38],1.0452050239208e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,19592,336,1.24 [1.05-1.46],0.0100156111127101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,17201,308,1.51 [1.14-2.00],0.0041196705107763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,19592,336,0.55 [0.43-0.70],5.973745643674218e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,17199,308,1.16 [1.01-1.34],0.0373521303112183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,16452,291,1.28 [1.04-1.59],0.0218342203821678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,19608,336,1.89 [1.60-2.24],1.974464865121145e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,17201,308,0.77 [0.67-0.90],0.0006621053571157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,19740,338,1.81 [1.53-2.14],4.421378895568193e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,19776,339,0.72 [0.54-0.97],0.0278019878719187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,19939,343,1.24 [1.06-1.44],0.0076134101600156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,19402,328,0.71 [0.58-0.86],0.0005076828211313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,17141,308,1.35 [1.20-1.51],3.215518763432552e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,17033,304,0.29 [0.20-0.43],1.1067881305604051e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,19829,337,2.55 [1.84-3.54],1.93944570160858e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,19950,342,1.25 [1.09-1.44],0.0014003658128027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,19639,330,1.20 [1.03-1.40],0.0192575965542062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,19764,335,1.51 [1.06-2.15],0.0230027625707964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,19592,336,1.77 [1.40-2.24],1.5189211858950875e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,19945,340,0.77 [0.65-0.92],0.0033644524746339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,19402,328,1.47 [1.27-1.71],2.222909523754701e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,19837,338,2.02 [1.46-2.81],2.721624023567891e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,19950,342,1.73 [1.26-2.36],0.0006084467111634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,19942,342,1.44 [1.23-1.68],7.240875639342036e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,16677,295,2.94 [2.00-4.32],3.687983121177333e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,19978,342,1.62 [1.25-2.09],0.0002283893386063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,17199,308,1.35 [1.01-1.82],0.0441421290651703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,17214,308,1.26 [1.07-1.49],0.0067721049412128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,19668,335,2.09 [1.66-2.64],5.605128472163312e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,17140,308,1.84 [1.58-2.13],9.098720048103286e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,19754,339,1.94 [1.57-2.41],1.4378275055453975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,19735,334,1.20 [1.03-1.40],0.0207395811553728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,19332,331,1.31 [1.07-1.59],0.0084256240557693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,19301,331,1.82 [1.35-2.46],9.953691375760668e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,19916,343,2.09 [1.69-2.58],1.2424660402322847e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,20015,341,1.28 [1.12-1.46],0.0002600515499158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",19776,339,1.58 [1.22-2.06],0.000638669375575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,19900,343,1.28 [1.10-1.49],0.001399663522289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,18815,314,2.27 [1.88-2.74],1.2012158397842076e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",19518,334,0.30 [0.24-0.39],1.5259217914943365e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,19939,343,1.63 [1.24-2.14],0.0005086911346991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,19413,332,1.80 [1.32-2.47],0.000222240536123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,19939,343,1.28 [1.08-1.51],0.0037927174366639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,17155,308,2.23 [1.61-3.09],1.4123850651531588e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,19402,328,1.37 [1.13-1.66],0.0016215767435989
